Erik Harris

Erik Harris

Director/Miembro de la Junta en REZOLUTE, INC. .

Fortuna: 3 M $ al 31/07/2026

56 años
Health Technology
Consumer Services
Commercial Services

Perfil

Erik C.
Harris
is an Independent Director at Rezolute, Inc. since 2025, Chief Commercial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. since 2019, and a Trustee at East Bay Zoological Society.
Former roles include Independent Director at Denali Therapeutics, Inc. from 2022 to 2025, Independent Director at Inozyme Pharma, Inc. from 2024 to 2025, Senior Director-Marketing & Sales at Elan Corp.
Plc, Manager-Sales & Marketing at Bristol Myers Squibb Co. from 1999 to 2001, Head-Sales & Marketing at Genentech, Inc. from 2003 to 2007, Vice President-Pulmonology Marketing at InterMune, Inc. from 2009 to 2010, and Vice President-Marketing & Sales at Crescendo Bioscience LLC from 2011 to 2017.
Education includes undergraduate studies at the United States Naval Academy and an MBA from The Wharton School of the University of Pennsylvania.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/04/2026 118.410 ( 0,12 % ) 3 M $ 31/07/2026
19/11/2025 0 ( -.--% ) - $ 31/07/2026

Cargos activos de Erik Harris

EmpresasCargoInicio
ULTRAGENYX PHARMACEUTICAL INC. Corporate Officer/Principal 01/01/2017
REZOLUTE, INC. Director/Miembro de la Junta 25/03/2025
Director/Miembro de la Junta -

Antiguos cargos conocidos de Erik Harris.

EmpresasCargoFin
INOZYME PHARMA, INC. Director/Miembro de la Junta 01/07/2025
DENALI THERAPEUTICS INC. Director/Miembro de la Junta 03/06/2025
Ventas & Marketing 01/06/2017
INTERMUNE INC Ventas & Marketing 01/08/2010
Corporate Officer/Principal 01/01/2007
Ver el detalle de la experiencia de Erik Harris.

Formación de Erik Harris.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

70

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology